These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15702198)

  • 1. Correcting the QT interval for changes in HR in pre-clinical drug development.
    Meyners M; Markert M
    Methods Inf Med; 2004; 43(5):445-50. PubMed ID: 15702198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculation of QT shift in non clinical safety pharmacology studies.
    Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
    J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
    Markert M; Shen R; Trautmann T; Guth B
    J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
    Tattersall ML; Dymond M; Hammond T; Valentin JP
    J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys.
    Holzgrefe HH; Cavero I; Gleason CR; Warner WA; Buchanan LV; Gill MW; Burkett DE; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(2):159-75. PubMed ID: 16857392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs.
    Ollerstam A; Visser SA; Persson AH; Eklund G; Nilsson LB; Forsberg T; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
    J Pharmacol Toxicol Methods; 2006; 53(2):174-83. PubMed ID: 16140023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.
    Mitchell AZ; Bills AJ; Wittwer GT; Foley CM; Kremer JJ; Chen H; Osinski MA
    J Pharmacol Toxicol Methods; 2013; 68(1):62-73. PubMed ID: 23639348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium.
    Holzgrefe H; Ferber G; Champeroux P; Gill M; Honda M; Greiter-Wilke A; Baird T; Meyer O; Saulnier M
    J Pharmacol Toxicol Methods; 2014; 69(1):61-101. PubMed ID: 23689033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.
    Ollerstam A; Visser SA; Duker G; Forsberg T; Persson AH; Nilsson LB; Björkman JA; Gabrielsson J; Al-Saffar A
    J Pharmacol Toxicol Methods; 2007; 56(2):131-44. PubMed ID: 17689270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of QT interval using a linear model in individual cynomolgus monkeys.
    Koga T; Kuwano K; Kito G; Kanefuji K
    J Pharmacol Toxicol Methods; 2007; 55(3):248-53. PubMed ID: 17141531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
    Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
    Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
    J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research.
    Van Deuren B; Van Ammel K; Somers Y; Cools F; Straetemans R; van der Linde HJ; Gallacher DJ
    J Pharmacol Toxicol Methods; 2009; 60(1):11-23. PubMed ID: 19422925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
    Batey AJ; Doe CP
    J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog.
    Ollerstam A; Persson AH; Visser SA; Fredriksson JM; Forsberg T; Nilsson LB; Eklund G; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
    J Pharmacol Toxicol Methods; 2007; 55(1):35-48. PubMed ID: 16581270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.
    Piotrovsky V
    AAPS J; 2005 Oct; 7(3):E609-24. PubMed ID: 16353940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach to correct the QT interval for changes in heart rate using a nonparametric regression model in beagle dogs.
    Watanabe H; Miyazaki H
    J Pharmacol Toxicol Methods; 2006; 53(3):234-41. PubMed ID: 16297641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.